Condition: Calcium Release Deficiency Syndrome · Sponsor: Population Health Research Institute
Calcium Release Deficiency Syndrome (CRDS) is a newly discovered genetic arrhythmia syndrome that confers a risk of life-threatening arrhythmias secondary to RYR2 loss-of-function. The International CRDS registry has been designed to facilitate large-scale evaluation of CRDS, including its phenotypic spectrum, approaches to risk stratification, and optimal treatment strategies.
This description comes directly from the study's public registry record.
Jason D Roberts, MD MAS · 905-297-3479 · crds@phri.ca
Always discuss trial participation with your own doctor first.
| University of California | San Francisco, California, United States | Recruiting |
| Mayo Clinic | Rochester, Minnesota, United States | Recruiting |
| Duke University | Durham, North Carolina, United States | Recruiting |
| Inova Health Care Services | Fairfax, Virginia, United States | Recruiting |
| Garvan Institute of Medical Research | Darlinghurst, New South Wales, Australia | Recruiting |
| Antwerp University Hospital | Edegem, Antwerp, Belgium | Recruiting |
| Universitair Ziekenhuis Brussel | Brussels, Belgium | Recruiting |
| University of Calgary | Calgary, Alberta, Canada | Recruiting |
| Children's & Women's Health Centre of British Columbia | Vancouver, British Columbia, Canada | Recruiting |
| Hamilton General Hospital | Hamilton, Ontario, Canada | Recruiting |
| London Health Sciences Centre - University Hospital | London, Ontario, Canada | Recruiting |
| Ottawa Heart Institute | Ottawa, Ontario, Canada | Recruiting |
+ 6 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06508164